Published in Gene Therapy Weekly, December 1st, 2011
The experimental agent, PF-03446962, targets activin receptor-like kinase 1 (ALK-1), which is part of the transforming growth factor ß (TGFß) superfamily of receptors that potentially...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly